Eloxx Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary

Eloxx Pharmaceuticals

07/05/2021 12:34

* Eloxx Pharmaceuticals Inc  ELOX.OQ  reported a quarterly
adjusted loss of 22 cents​​ per share for the quarter ended
in March. The mean expectation of two analysts for the quarter
was for a loss of 16 cents per share.
* Revenue was $0.00​​;  analysts expected $0.00.
* Eloxx Pharmaceuticals Inc's reported EPS for the quarter was a
loss of 22 cents​.
* The mean earnings estimate of analysts had risen by
about 11.1% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Eloxx Pharmaceuticals Inc shares had fallen by 38.3% this
quarter and lost 48.5% so far this year.
* The company reported a quarterly loss of $8.69 million.
* Wall Street's median 12-month price target for Eloxx
Pharmaceuticals Inc is $4.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 
This summary was machine generated May 7 at 11:34 a.m. GMT. ​All
figures in US Dollars.​